The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Kevin Campbell from the University of North Carolina: Finding Best Ways to Engage on Social Media
How a doctor presents themselves on social media can determine how effective it is in getting their message across while also maintaining a safe barrier between them and their patients.
Frank W. Peacock IV from Baylor College of Medicine: Rivaroxaban Shows Benefits for Diabetics
As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.
10 Awkward Patient-Doctor Moments
April 5th 2016When you become a doctor, it’s no secret that you will have to deal with people all day long. And, in the course of these many human interactions (sometimes under stressful circumstances), there are bound to be some awkward, uncomfortable and painfully silent moments.
The Complex Relationship between Depression, Diabetes, and St. Johns Wort
April 4th 2016Researchers report that St. John’s Wort produces persistent glucose intolerance via decreased beta-cell function. St. John’s Wort may increase risk of type 2 diabetes in the already at-risk depressed population.
People with Advanced Chronic Kidney Disease Need More Vitamin D
April 1st 2016Vitamin D has shown to play an important role in those with multiple sclerosis, chronic obstructive pulmonary disease (COPD), and even depression; now it looks like the same can be said about those with stage 3 or 4 chronic kidney disease (CKD).